Company intelligence / Profile preview

Pharmaceutical Strategies Group

Plano, Texas, United Statespsgconsults.com ↗

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

PSG provides pharmacy benefit consulting and drug cost management solutions to health plans, employers, and healthcare systems. Its proprietary Artemetrx platform delivers actionable insights from integrated pharmacy and medical claims data. The company has generated billions in drug cost savings for clients representing over 20 million lives. It publishes industry-leading research on pharmacy benefit trends and specialty drug spend. In 2020, its 340B Link software-enabled service business was acquired by Omnicell for $225 million. Now operates as an EPIC company.

Industry: Consulting

Partnerships

No major pharma/biotech partnerships reported; works with >200 clients including health plans/employers/healthcare systems

Beyond the preview

Go deeper on Pharmaceutical Strategies Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharmaceutical Strategies Group.

Explore the full profile